A Study on Docking Mode of HIV Protease and Their Inhibitors.
- 1 January 2001
- journal article
- Published by Society of Computer Chemistry Japan in Journal of Chemical Software
- Vol. 7 (3) , 103-114
- https://doi.org/10.2477/jchemsoft.7.103
Abstract
The capability to propose feasible ways of binding a putative ligand inhibitor to a known receptor site is crucial to the successful structure-based drug design. A computer docking approach is to position or "dock" ligand and receptor molecules together in many different ways and then score each orientation by applying a reasonable evaluation func- tion. AutoDock3.0 is an unbiased type docking program in which a user does not have to direct a ligand to an active site, but the system finds an optimal position after a ligand is placed in a random manner. Synthesized derivatives of the intact inhibitor (inh1) of HIV protease were investigated for their docking modes as compared with their Ki values. Among the derivatives, inh3trans and inh6H were found to be more powerful inhibitors of HIV protease than the others. Gibbs free energy calculated by applying molecular me- chanics interaction energies was compared with the one obtained by using experimental inhibitory potencies for a series of HIV protease inhibitors, and a fairly good correlation was found between the two. Based on this favorable correlationship between the com- putational and the experimental results, the computational experiments were pursued for the compounds drawn by Sybyl taking into consideration the fact that unexploited car- bon affinity regions (or hydrophobic regions) with sizable volume were detected on the docking study of inh1 and inh8 against HIV protease. Those were compounds with a t-butyl substituted by various hydrophobic side chains. Among those a compound with a benzyl group exhibited the lowest docking energy. Since one of the goals of this paper was to perform the computational drug-design experiment to investigate potential HIV protease inhibitors, the authors would like to leave the clinical investigational work for the expertise of those areas.Keywords
This publication has 15 references indexed in Scilit:
- Identification of Efficiently Cleaved Substrates for HIV-1 Protease Using a Phage Display Library and Use in Inhibitor DevelopmentVirology, 2000
- Development of a New Type of Protease Inhibitors, Efficacious against FIV and HIV VariantsJournal of the American Chemical Society, 1999
- HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes.Journal of Clinical Investigation, 1998
- Optimizing the Binding of Fullerene Inhibitors of the HIV-1 Protease through Predicted Increases in Hydrophobic DesolvationJournal of Medicinal Chemistry, 1998
- Comparative Binding Energy Analysis of HIV-1 Protease Inhibitors: Incorporation of Solvent Effects and Validation as a Powerful Tool in Receptor-Based Drug DesignJournal of Medicinal Chemistry, 1998
- A Novel Nonpeptide HIV-1 Protease Inhibitor: Elucidation of the Binding Mode and Its Application in the Design of Related AnalogsJournal of Medicinal Chemistry, 1994
- Automated docking in crystallography: Analysis of the substrates of aconitaseProteins-Structure Function and Bioinformatics, 1993
- LUDI: rule-based automatic design of new substituents for enzyme inhibitor leadsJournal of Computer-Aided Molecular Design, 1992
- Prediction of the structure of a receptor–protein complex using a binary docking methodNature, 1992
- A geometric approach to macromolecule-ligand interactionsJournal of Molecular Biology, 1982